Global Ankylosing Spondylitis Drug Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Ankylosing Spondylitis Drug

• 1.1 Definition of Ankylosing Spondylitis Drug
• 1.2 Ankylosing Spondylitis Drug Segment by Type
  • 1.2.1 Global Ankylosing Spondylitis Drug Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Cimzia
  • 1.2.3 Enbrel
  • 1.2.4 Humira
  • 1.2.5 Remicade
  • 1.2.6 Simponi
  • 1.2.7 Others
• 1.3 Ankylosing Spondylitis Drug Segment by Applications
  • 1.3.1 Global Ankylosing Spondylitis Drug Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hospitals
  • 1.3.3 Clinics
• 1.4 Global Ankylosing Spondylitis Drug Overall Market
  • 1.4.1 Global Ankylosing Spondylitis Drug Revenue (2014-2025)
  • 1.4.2 Global Ankylosing Spondylitis Drug Production (2014-2025)
  • 1.4.3 North America Ankylosing Spondylitis Drug Status and Prospect (2014-2025)
  • 1.4.4 Europe Ankylosing Spondylitis Drug Status and Prospect (2014-2025)
  • 1.4.5 China Ankylosing Spondylitis Drug Status and Prospect (2014-2025)
  • 1.4.6 Japan Ankylosing Spondylitis Drug Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Ankylosing Spondylitis Drug Status and Prospect (2014-2025)
  • 1.4.8 India Ankylosing Spondylitis Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Ankylosing Spondylitis Drug
• 2.3 Manufacturing Process Analysis of Ankylosing Spondylitis Drug
• 2.4 Industry Chain Structure of Ankylosing Spondylitis Drug

3 Development and Manufacturing Plants Analysis of Ankylosing Spondylitis Drug

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Ankylosing Spondylitis Drug Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Ankylosing Spondylitis Drug
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Ankylosing Spondylitis Drug Production and Capacity Analysis
• 4.2 Ankylosing Spondylitis Drug Revenue Analysis
• 4.3 Ankylosing Spondylitis Drug Price Analysis
• 4.4 Market Concentration Degree

5 Ankylosing Spondylitis Drug Regional Market Analysis

• 5.1 Ankylosing Spondylitis Drug Production by Regions
  • 5.1.1 Global Ankylosing Spondylitis Drug Production by Regions
  • 5.1.2 Global Ankylosing Spondylitis Drug Revenue by Regions
• 5.2 Ankylosing Spondylitis Drug Consumption by Regions
• 5.3 North America Ankylosing Spondylitis Drug Market Analysis
  • 5.3.1 North America Ankylosing Spondylitis Drug Production
  • 5.3.2 North America Ankylosing Spondylitis Drug Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Ankylosing Spondylitis Drug Import and Export
• 5.4 Europe Ankylosing Spondylitis Drug Market Analysis
  • 5.4.1 Europe Ankylosing Spondylitis Drug Production
  • 5.4.2 Europe Ankylosing Spondylitis Drug Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Ankylosing Spondylitis Drug Import and Export
• 5.5 China Ankylosing Spondylitis Drug Market Analysis
  • 5.5.1 China Ankylosing Spondylitis Drug Production
  • 5.5.2 China Ankylosing Spondylitis Drug Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Ankylosing Spondylitis Drug Import and Export
• 5.6 Japan Ankylosing Spondylitis Drug Market Analysis
  • 5.6.1 Japan Ankylosing Spondylitis Drug Production
  • 5.6.2 Japan Ankylosing Spondylitis Drug Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Ankylosing Spondylitis Drug Import and Export
• 5.7 Southeast Asia Ankylosing Spondylitis Drug Market Analysis
  • 5.7.1 Southeast Asia Ankylosing Spondylitis Drug Production
  • 5.7.2 Southeast Asia Ankylosing Spondylitis Drug Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Ankylosing Spondylitis Drug Import and Export
• 5.8 India Ankylosing Spondylitis Drug Market Analysis
  • 5.8.1 India Ankylosing Spondylitis Drug Production
  • 5.8.2 India Ankylosing Spondylitis Drug Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Ankylosing Spondylitis Drug Import and Export

6 Ankylosing Spondylitis Drug Segment Market Analysis (by Type)

• 6.1 Global Ankylosing Spondylitis Drug Production by Type
• 6.2 Global Ankylosing Spondylitis Drug Revenue by Type
• 6.3 Ankylosing Spondylitis Drug Price by Type

7 Ankylosing Spondylitis Drug Segment Market Analysis (by Application)

• 7.1 Global Ankylosing Spondylitis Drug Consumption by Application
• 7.2 Global Ankylosing Spondylitis Drug Consumption Market Share by Application (2014-2019)

8 Ankylosing Spondylitis Drug Major Manufacturers Analysis

• 8.1 Amgen
  • 8.1.1 Amgen Ankylosing Spondylitis Drug Production Sites and Area Served
  • 8.1.2 Amgen Product Introduction, Application and Specification
  • 8.1.3 Amgen Ankylosing Spondylitis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Wyeth
  • 8.2.1 Wyeth Ankylosing Spondylitis Drug Production Sites and Area Served
  • 8.2.2 Wyeth Product Introduction, Application and Specification
  • 8.2.3 Wyeth Ankylosing Spondylitis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 Takeda
  • 8.3.1 Takeda Ankylosing Spondylitis Drug Production Sites and Area Served
  • 8.3.2 Takeda Product Introduction, Application and Specification
  • 8.3.3 Takeda Ankylosing Spondylitis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Centocor
  • 8.4.1 Centocor Ankylosing Spondylitis Drug Production Sites and Area Served
  • 8.4.2 Centocor Product Introduction, Application and Specification
  • 8.4.3 Centocor Ankylosing Spondylitis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served
• 8.5 Schering-Plough
  • 8.5.1 Schering-Plough Ankylosing Spondylitis Drug Production Sites and Area Served
  • 8.5.2 Schering-Plough Product Introduction, Application and Specification
  • 8.5.3 Schering-Plough Ankylosing Spondylitis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.5.4 Main Business and Markets Served
• 8.6 Mitsubishi Tanabe
  • 8.6.1 Mitsubishi Tanabe Ankylosing Spondylitis Drug Production Sites and Area Served
  • 8.6.2 Mitsubishi Tanabe Product Introduction, Application and Specification
  • 8.6.3 Mitsubishi Tanabe Ankylosing Spondylitis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.6.4 Main Business and Markets Served
• 8.7 Abbott
  • 8.7.1 Abbott Ankylosing Spondylitis Drug Production Sites and Area Served
  • 8.7.2 Abbott Product Introduction, Application and Specification
  • 8.7.3 Abbott Ankylosing Spondylitis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.7.4 Main Business and Markets Served
• 8.8 Eisai
  • 8.8.1 Eisai Ankylosing Spondylitis Drug Production Sites and Area Served
  • 8.8.2 Eisai Product Introduction, Application and Specification
  • 8.8.3 Eisai Ankylosing Spondylitis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.8.4 Main Business and Markets Served
• 8.9 Pfizer
  • 8.9.1 Pfizer Ankylosing Spondylitis Drug Production Sites and Area Served
  • 8.9.2 Pfizer Product Introduction, Application and Specification
  • 8.9.3 Pfizer Ankylosing Spondylitis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.9.4 Main Business and Markets Served
• 8.10 Johnson & Johnson
  • 8.10.1 Johnson & Johnson Ankylosing Spondylitis Drug Production Sites and Area Served
  • 8.10.2 Johnson & Johnson Product Introduction, Application and Specification
  • 8.10.3 Johnson & Johnson Ankylosing Spondylitis Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.10.4 Main Business and Markets Served

9 Development Trend of Analysis of Ankylosing Spondylitis Drug Market

• 9.1 Global Ankylosing Spondylitis Drug Market Trend Analysis
  • 9.1.1 Global Ankylosing Spondylitis Drug Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Ankylosing Spondylitis Drug Regional Market Trend
  • 9.2.1 North America Ankylosing Spondylitis Drug Forecast 2019-2025
  • 9.2.2 Europe Ankylosing Spondylitis Drug Forecast 2019-2025
  • 9.2.3 China Ankylosing Spondylitis Drug Forecast 2019-2025
  • 9.2.4 Japan Ankylosing Spondylitis Drug Forecast 2019-2025
  • 9.2.5 Southeast Asia Ankylosing Spondylitis Drug Forecast 2019-2025
  • 9.2.6 India Ankylosing Spondylitis Drug Forecast 2019-2025
• 9.3 Ankylosing Spondylitis Drug Market Trend (Product Type)
• 9.4 Ankylosing Spondylitis Drug Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Ankylosing Spondylitis Drug Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List